Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Forte Biosciences News

    0,65 € -2,26% -0,015 €
    08:13:15 Uhr Frankfurt aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2P611
    ISIN: US34962G1094
    US-Symbol: FBRX
    Typ: Aktie

    Forte Biosciences News

    03.09.21 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forte Biosciences, Inc. - FBRX
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forte Biosciences, Inc. - FBRX PR Newswire
    03.09.21 - PR Newswire
    Thinking about buying stock in Meta Materials, Cellect Biotechnology, Forte Biosciences, Camber Energy, or Denison Mines?
    Thinking about buying stock in Meta Materials, Cellect Biotechnology, Forte Biosciences, Camber Energy, or Denison Mines? PR Newswire
    28.05.20 - PR Newswire
    Tocagen Announces Change to Virtual Format for Special Meeting of Stockholders
    Tocagen Announces Change to Virtual Format for Special Meeting of Stockholders PR Newswire
    23.04.20 - PR Newswire
    Tocagen Reports First Quarter 2020 Financial Results
    Tocagen Reports First Quarter 2020 Financial Results PR Newswire
    15.04.20 - PR Newswire
    Thinking about buying stock in Aphria, Chesapeake Energy Corp, JetBlue Airways, Tocagen, or Verizon?
    Thinking about buying stock in Aphria, Chesapeake Energy Corp, JetBlue Airways, Tocagen, or Verizon? PR Newswire
    11.03.20 - Der Aktionär
    Diese Aktien trotzen der Korrektur
    27.02.20 - PR Newswire
    Tocagen Reports Fourth Quarter and Full Year 2019 Financial Results
    Tocagen Reports Fourth Quarter and Full Year 2019 Financial Results Definitive merger agreement with Forte Biosciences announced February 19, 2020 PR Newswire
    24.02.20 - PR Newswire
    Thinking about buying stock in Aurora Cannabis, Barrick Gold Corp, Micron, Sprouts Farmers Market, or Tocagen?
    Thinking about buying stock in Aurora Cannabis, Barrick Gold Corp, Micron, Sprouts Farmers Market, or Tocagen? PR Newswire
    19.02.20 - PR Newswire
    Tocagen and Forte Biosciences Announce Merger
    Tocagen and Forte Biosciences Announce Merger Transaction to Create Nasdaq-​listed Company Focused on Advancing Forte's Late-​Stage Clinical Program for Atopic Dermatitis ...
    22.11.19 - PR Newswire
    Toca 5 Phase 3 Trial Results Presented at the Society for Neuro-Oncology Annual Meeting
    Toca 5 Phase 3 Trial Results Presented at the Society for Neuro-​Oncology Annual Meeting PR Newswire
    22.11.19 - PR Newswire
    Toca 5 Phase 3 Trial Results Presented at the Society for Neuro-Oncology Annual Meeting
    Toca 5 Phase 3 Trial Results Presented at the Society for Neuro-​Oncology Annual Meeting PR Newswire
    12.11.19 - PR Newswire
    Tocagen Reports Third Quarter 2019 Financial Results and Business Updates
    Tocagen Reports Third Quarter 2019 Financial Results and Business Updates PR Newswire
    08.11.19 - PR Newswire
    Tocagen Highlights Toca 6 Phase 1b Data at Society for Immunotherapy of Cancer Annual Meeting
    Tocagen Highlights Toca 6 Phase 1b Data at Society for Immunotherapy of Cancer Annual Meeting Phase 3 Toca 5 trial data and details on planned trial in newly diagnosed ...
    06.11.19 - PR Newswire
    Tocagen to Report Third Quarter 2019 Financial Results and Business Updates on Tuesday, November 12
    Tocagen to Report Third Quarter 2019 Financial Results and Business Updates on Tuesday, November 12 PR Newswire
    03.10.19 - PR Newswire
    Tocagen Announces Restructuring to Focus on Clinical Development
    Tocagen Announces Restructuring to Focus on Clinical Development Toca 5 full results to be presented at the upcoming Society for Neuro-​Oncology Annual Meeting PR Newswire
    12.09.19 - PR Newswire
    Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
    Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer Management to host conference call today at 8:30 a.m. Eastern PR Newswire
    26.08.19 - PR Newswire
    Tocagen to Participate in Two Upcoming Investor Conferences
    Tocagen to Participate in Two Upcoming Investor Conferences PR Newswire
    01.08.19 - PR Newswire
    Tocagen to Report Second Quarter 2019 Financial Results and Business Updates on Thursday, August 8
    Tocagen to Report Second Quarter 2019 Financial Results and Business Updates on Thursday, August 8 PR Newswire
    30.05.19 - PR Newswire
    Tocagen to Present at Upcoming Jefferies 2019 Healthcare Conference
    Tocagen to Present at Upcoming Jefferies 2019 Healthcare Conference PR Newswire
    21.05.19 - PR Newswire
    Tocagen's Toca 5 Pivotal Phase 3 Clinical Trial in Patients with Recurrent Brain Cancer Continues Without Modification at Planned Interim Analysis
    Tocagen's Toca 5 Pivotal Phase 3 Clinical Trial in Patients with Recurrent Brain Cancer Continues Without Modification at Planned Interim Analysis PR Newswire

    Newssuche

    Videos

    newspaper
    09:10 Uhr
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »